4.6 Article

PROTEOMIC ANALYSIS OF HUMAN MESENTERIC LYMPH

Journal

SHOCK
Volume 35, Issue 4, Pages 331-338

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SHK.0b013e318206f654

Keywords

Mesenteric lymph; neutrophil; superoxide; proteomics; trauma; hemorrhagic shock; multiple organ failure; acute lung injury

Funding

  1. National Institutes of Health through the University of Colorado Comprehensive Cancer Center [P30 CA046934-17]
  2. National Center for Research Resources [S10RR023015]
  3. National Institutes of Health [P50GM049222, T32GM008315]

Ask authors/readers for more resources

Extensive animal work has established mesenteric lymph as the mechanistic link between gut ischemia/reperfusion and distant organ injury. Our trauma and transplant services provide a unique opportunity to assess the relevance of our animal data to human mesenteric lymph under conditions that simulate those used in the laboratory. Mesenteric lymph was collected from 11 patients with lymphatic injuries, during semielective spine reconstruction or immediately before organ donation. The lymph was tested for its ability to activate human neutrophils in vitro and was analyzed by label-free proteomic analysis. Human mesenteric lymph primed human polymorphonuclear neutrophils in a pattern similar to that observed in previous rodent, swine, and primate studies. A total of 477 proteins were identified from the 11 subjects' lymph samples with greater than 99% confidence. In addition to classic serum proteins, markers of hemolysis, extracellular matrix components, and general tissue damage were identified. Both tissue injury and shock correlate strongly with production of bioactive lymph. Products of red blood cell hemolysis correlate strongly with human lymph bioactivity, and immunoglobulins have a negative correlation with the proinflammatory lymph. These human data corroborate the current body of research implicating postshock mesenteric lymph in the development of systemic inflammation and multiple organ failure. Further studies will be required to determine if the proteins identified participate in the pathogenesis of multiple organ failure and if they can be used as diagnostic markers.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available